gvtcx

SARS-CoV-2 Adult Vaccine Supply (2026)

UK Health Security Agency Published 25 Jun 2026 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£1
Statuscomplete
Category (CPV) 33651600
Deadline31 Mar 2026
Contract start10 Jun 2026
Contract end9 Mar 2027
Procedureselective
SME suitableNo
OCIDocds-b5fd17-39975ef6-f110-4339-a87e-e5c62dd67173

Award

SupplierValueDateStatus
ACCORD-UK LTD £1 9 Jun 2026 active

description

Contract for the supply of immunisation products indicated for the prevention of, or protection against, SARS-CoV-2 in Adults (2026).

A single contract has been awarded for two Lots: Lot 1, Adult SARS-CoV-2 vaccines with a shelf-life of 10 weeks or greater at 2°C to 8°C & Lot 2, non-mRNA SARS-CoV-2 vaccines, via a further competition conducted under the SARS-CoV-2 vaccine DPS (FTS ref: 2024/S 000-026083).

Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
25 Jun 2026 Award (award) · 53bb81c5-1ed8-40c2-8d48-b9ec4c9a8248-903596

more from UK Health Security Agency

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.